Among nivolumab‐treated patients with NSCLC with good PS, the univariate analysis revealed that smoking status, driver mutation, LDH, CRP, liver metastasis, pleural effusion, and steroid use were significantly associated with PFS. Here, CRP is linked to non-small cell lung carcinoma.